Loading patent…
AssigneeEndonovo Therapeutics, Inc.
InventorArthur A. Pilla
Estimating the term…
Apparatus and methods for delivering electromagnetic signals configured specifically to accelerate the asymmetrical kinetics of the binding of intracellular ions to their respective intracellular buffers, to enhance the biochemical signaling pathways plant animal and human molecules, cells, tissues, organs, portions of entire organisms and entire organisms employ for growth, repair and maintenance. Described herein are devices and methods that utilize repetitive bursts of waveforms configured to maximize the bound concentration of intracellular ions at their associated molecular buffers to enhance the biochemical signaling pathways living systems employ for growth, repair and maintenance. For example the systems and methods described herein may drive the binding of calcium to calmodulin (CaM), thereby enhancing the CaM-dependent nitric oxide (NO)/cyclic guanosine monophosphate (cGMP) signaling pathway.
A method for electromagnetic treatment of plants, animals, and humans by accelerating ion binding to a corresponding molecule in a target pathway, the target pathway operating at a voltage, to modulate activity of biochemical signaling pathways plants, animals and humans employ for tissue growth, repair and maintenance, the method comprising:
A method for electromagnetic treatment of plants, animals, and humans by accelerating ion binding to a corresponding molecule in a target pathway, the target pathway operating at a voltage, to modulate activity of biochemical signaling pathways plants, animals and humans employ for tissue growth, repair and maintenance, the method comprising:
A method of treating a region of a patient's body to enhance calmodulin-dependent signaling pathways, the method comprising:
A method of treating a region of a patient's body to enhance calmodulin-dependent signaling pathways, the method comprising:
A method of applying a wearable electromagnetic treatment device to modulate the binding of calcium to calmodulin in a target tissue by applying electromagnetic waveforms to a tissue that match asymmetrical kinetic of binding of calcium to calmodulin, thereby enhancing calmodulin-dependent signaling, the method comprising:
Dependencies are inferred from the claim text.